“Methylene Bridge” to 5-HT3 Receptor Antagonists: Conformationally Constrained Phenylguanidines-Reference-Cited by-同舟云学术

“Methylene Bridge” to 5-HT3 Receptor Antagonists: Conformationally Constrained Phenylguanidines

Published:2018-10-30 Issue:3 Volume:10 Page:1380-1389
ISSN:1948-7193
Container-title:ACS Chemical Neuroscience
language:en
Short-container-title:ACS Chem. Neurosci.

Author:

Abdelkhalek Ahmed S.¹,Alley Genevieve S.¹,Alwassil Osama I.¹,Khatri Shailesh²,Mosier Philip D.¹,Nyce Heather L.³,White Michael M.³,Schulte Marvin K.²,Dukat Małgorzata¹^ORCID

Affiliation:

1. Department of Medicinal Chemistry, School of Pharmacy, Virginia Commonwealth University, Richmond, Virginia 23298, United States

2. Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, Pennsylvania 19104, United States

3. Department of Biochemistry and Molecular Biology, College of Medicine, Drexel University, Philadelphia, Pennsylvania 19102, United States

Publisher

American Chemical Society (ACS)

Subject

Cell Biology,Cognitive Neuroscience,Physiology,Biochemistry,General Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acschemneuro.8b00431

Reference23 articles.

1. 5-HT3 receptors: Role in disease and target of drugs

2. Recent developments in 5-HT3 receptor pharmacology

3. From Chemotherapy-Induced Emesis to Neuroprotection: Therapeutic Opportunities for 5-HT3 Receptor Antagonists

4. The neuronal 5-HT3 receptor network after 20 years of research — Evolving concepts in management of pain and inflammation

5. Is There a Role for 5-HT3Receptor Antagonists in the Treatment of Opioid-Induced Pruritus?

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational design of novel compounds to serve as potential NDM-1 inhibitors using molecular docking, molecular dynamics simulation, and physicochemical studies;Molecular Simulation;2023-07-12

2. N1H- and N1-Substituted Phenylguanidines as α7 Nicotinic Acetylcholine (nACh) Receptor Antagonists: Structure–Activity Relationship Studies;ACS Chemical Neuroscience;2021-05-27

3. X-ray crystal structure of a 2-amino-3,4-dihydroquinazoline 5-HT3 serotonin receptor antagonist and related analogs;Journal of Molecular Structure;2020-02